Rearsh Centre on Aging
Sherbrooke, Quebec, J1H4C4, Canada
NCT Number: NCT04580823
Participants will undergo 3 Positron Emission Tomography (PET) scans in 3 different conditions :
1. Fasting without exogenous ketone salt 2. Fasting with exogenous ketone salt supplement 3. Post-Prandial with exogenous ketone salt supplement.
Looking for future studies?
Notify Me45 year–64 year
All sexes
Interventional
Not applicable
Sherbrooke, Quebec, J1H4C4, Canada
This study will help to quantify heart and kidney ketone uptake with or without an exogenous ketone salt with or without food intake in middle-aged adults. Participants will have 3 different PET scan to perform :
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will have to take 2 doses of supplement, one 75 minutes before the scan and one 30 minutes before the scan.
Other names: Post-Prandial with exogenous ketone salt supplement
Participants will have to take 2 doses of supplement, one 75 minutes before the scan and one 30 minutes before the scan and they will have a liquid meal 20 minutes before the scan.
Time frame: 60 minutes
Heart ketone uptake measured by PET scan
Time frame: 60 minutes
Kidney ketone uptake measured by PET scan
Time frame: 60 minutes
telediastolic volume
Time frame: 60 minutes
telesystolic volume
Time frame: 60minutes
Ejection fraction
Time frame: 60 minutes
Plasma ketone concentration
Université de Sherbrooke
Other
Exogenous Ketone Salt on Heart and Kidney Ketone Metabolism Measured by Positron Emission Tomography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details